Table 3 Amniotic and maternal laboratory findings of participants
From: Oxidative stress biomarkers as novel screening tools for trisomy 21: a case-control study
Variables | Non-DS pregnancies (n = 37) | DS pregnancies (n = 28) | P value |
|---|---|---|---|
NQO1-AS (ng/ml) | 505.62 ± 358.17 | 924.84 ± 475.94 | < 0.001 |
NQO1-MS (ng/ml) | 394.87 ± 344.86 | 716.216 ± 242.91 | < 0.001 |
NFKB-AS (ng/ml) | 2.51 ± 0.86 | 2.57 ± 0.75 | 0.783 |
NFKB-MS (ng/ml) | 2.21 ± 1.45 | 2.80 ± 1.89 | 0.178 |
NRF2-AS (ng/ml) | 6.47 ± 5.53 | 3.77 ± 4.20 | 0.029 |
NRF2-MS (ng/ml) | 14.46 ± 16.53 | 7.54 ± 5.68 | 0.022 |
CSE-AS (ng/ml) | 10.13 ± 7.89 | 12.21 ± 7.40 | 0.280 |
CSE-MS (ng/ml) | 9.17 ± 11.02 | 16.68 ± 17.07 | 0.049 |